Navigation Links
Sigma-Aldrich Announces SAGE(TM) Priority Partners Program; Seeks Researchers to Evaluate New Knockout Rat Models
Date:10/20/2009

ST. LOUIS, Oct. 20 /PRNewswire-FirstCall/ -- Sigma-Aldrich® (Nasdaq: SIAL) today announced the launch of the SAGE(TM) Priority Partners Program, through which the Company plans to build a network of researchers to evaluate the 'knockout' rat models it is developing to support pre-clinical research work across a number of medical fields, including Neurobiology, Toxicology, Cardiology, Immunology and others.

The partner program, managed by Sigma Advanced Genetic Engineering (SAGE(TM)) Labs, a Sigma® Life Science initiative based in St. Louis, MO., effectively aims to validate the Company's portfolio of genetically-engineered rodent research models, developed using Sigma-Aldrich's proprietary CompoZr(TM) Zinc Finger Nuclease (ZFN) gene editing technology, which enables scientists to deactivate or 'knockout' specific genes that are associated with human disease.

Partners will be asked to conduct their own evaluation studies and provide feedback, and in return will be offered a number of benefits, including first access to new knockout models and ordering priority and fulfillment, as well as participating in the establishment of the research and development pipeline for this technology.

"The real value of our knockout rat models will lie in the phenotypes that they display," commented Dr. Edward Weinstein, Director of SAGE Labs. "As a result, we are actively seeking experts in the field who are interested in the initial validation of these animals as part of our exclusive SAGE Priority Partners Program."

Initially, SAGE Labs will be working on knockout rat models that target over 20 genes across a number of research areas. One example is Neurobiology, where knockout rat models are being developed with conditions such as Schizophrenia, Parkinson's Disease, Obesity and Alzheimer's. The initial po
'/>"/>

SOURCE Sigma-Aldrich
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells
2. Sangamo BioSciences and Sigma-Aldrich Announce Publication of Study Demonstrating Zinc Finger Technology for Rapid Generation of Knock-Out Cell Lines
3. Sigma-Aldrich(R) Receives Award From Michael J. Fox Foundation to Develop Parkinsons Disease Research Models
4. Sigma-Aldrich (Nasdaq: SIAL) Announces Appointment of George Miller as Sr. Vice President, General Counsel & Secretary
5. Sigma-Aldrich(R) Partners With Flow Chemistry Leader ThalesNano to Provide CatCart(R) Catalyst Products for Rapidly Growing Market
6. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
7. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
8. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
9. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
10. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
11. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2010)... Mass. , Feb. 9 Echo ... the needle-free Symphony™ tCGM System as a non-invasive, wireless, ... SkinPrep System for transdermal drug delivery, announced today that ... and CEO, will be interviewed on " Steve Crowley ... 9, 2010 at 9:34 AM ET ...
(Date:2/9/2010)... Feb. 9 Glycemion Strategies, Inc., ... initiatives for diabetic consumers and their professional healthcare ... Retrieval Program to benefit the 30,000 US Diabetes ... clients they serve. ,, The Portrait ... designed to provide real-time access to health information, ...
(Date:2/9/2010)... 9 Takeda Global Research & ... that it has initiated a trial to study ... (PPIs) affect the pharmacokinetics and pharmacodynamics of Plavix ... evaluating all published data and communications from the ... potential risks associated with concomitant use of clopidogrel ...
Breaking Medicine Technology:Echo Therapeutics Chairman and CEO to be Interviewed on Steve Crowley's American Scene Radio Program and Featured on Money Channel Inc. 2Echo Therapeutics Chairman and CEO to be Interviewed on Steve Crowley's American Scene Radio Program and Featured on Money Channel Inc. 3Echo Therapeutics Chairman and CEO to be Interviewed on Steve Crowley's American Scene Radio Program and Featured on Money Channel Inc. 4Portrait Health(TM) Emergency Medical Data Retrieval Program-Glycemion Strategies Announces Free Membership for Diabetes Educators 2Portrait Health(TM) Emergency Medical Data Retrieval Program-Glycemion Strategies Announces Free Membership for Diabetes Educators 3Takeda Announces Initiation of Trial to Study the Concomitant Use of Dexlansoprazole and Other Proton Pump Inhibitors with Plavix(R) (clopidogrel bisulfate) 2Takeda Announces Initiation of Trial to Study the Concomitant Use of Dexlansoprazole and Other Proton Pump Inhibitors with Plavix(R) (clopidogrel bisulfate) 3Takeda Announces Initiation of Trial to Study the Concomitant Use of Dexlansoprazole and Other Proton Pump Inhibitors with Plavix(R) (clopidogrel bisulfate) 4Zymes LLCs Omega 3 Enhanced Water OmegaChill to be Distributed at NFL Alumni Super Bowl XLIV Weekend Events on February 5 7th 2010 11681 1Zymes LLCs Omega 3 Enhanced Water OmegaChill to be Distributed at NFL Alumni Super Bowl XLIV Weekend Events on February 5 7th 2010 11681 2Spherical cows help to dump metabolism law 65790 1Spherical cows help to dump metabolism law 65790 2Spherical cows help to dump metabolism law 65790 3Finland invests 26 23128 3B1 85 million in pan European infrastructure for biomedical research 11680 1Finland invests 26 23128 3B1 85 million in pan European infrastructure for biomedical research 11680 2
... FORT WORTH, Texas, Sept. 30 Wound Care,Innovations, ... (OTC,Bulletin Board: WNDM), announced today that it will ... and Economical Realities in Boston. This,seminar is presented ... Wound Clinic, Podiatry Today and producers of the ...
... ROCKVILLE, Md., Sept. 29 Obese school-age,kids and ... gain if they,participate in medium- to high-intensity behavioral ... by HHS, Agency for Healthcare,Research and Quality., ... studied met for more than 25 hours, usually ...
Other Medicine Technology:Wound Management Technologies, Inc. Announces Conference Plans in Boston and Additional Clinical Research on CellerateRx(R) 2Behavioral Modification Programs Help Obese Children Manage Their Weight 2Behavioral Modification Programs Help Obese Children Manage Their Weight 3
(Date:2/9/2010)... See Idaho Lose $1.6 Billion from Feds & ... Feb. 9 As the Idaho House approved ... health care law, the long-term effects of the move could ... Idaho Health Freedom Act (House Bill 391) a disastrous and ... see Idaho lose nearly $1.6 billion ...
(Date:2/9/2010)... more soft drinks per week increased the risk of ... who did not consume soft drinks, according to a ... a journal of the American Association for Cancer Research. ... of the most deadly; only 5 percent of people ... Pereira, Ph.D., senior author on the study and associate ...
(Date:2/9/2010)... D.C. (February 9, 2010) AcademyHealth today recognized research ... the 2010 Health Services Research (HSR) Impact Award. ... a tool to ensure adherence to basic safety ... AcademyHealth recognizes research that clearly translated into policy ... said AcademyHealth President W. David Helms, Ph.D. "The ...
(Date:2/9/2010)... diagnosis among black women remained 30 percent to 90 ... 2004, according to new findings by researchers at Fred ... the incidence of advance colorectal cancer actually widened over ... increased slightly among blacks. , The findings are published ... Hormones and Cancer , a publication of the Endocrine ...
(Date:2/9/2010)... (LMW-E) forms of the protein cyclin E renders ... estrogen-receptor-positive (ER+) breast cancers, researchers from The University ... in Clinical Cancer Research . , The ... Ph.D., professor in M. D. Anderson,s Department of ... Olive Stringer Professor in Medical Oncology, found evidence ...
Breaking Medicine News(10 mins):Health News:Idaho House Moves State Closer to Health Care Disaster 2Health News:Idaho House Moves State Closer to Health Care Disaster 3Health News:Idaho House Moves State Closer to Health Care Disaster 4Health News:Soft drinks may increase risk of pancreatic cancer 2Health News:2010 HSR Impact Award recognizes surgical safety research 2Health News:Racial disparities persist in the diagnosis of advanced breast cancer and colon cancer in the U.S. 2Health News:Racial disparities persist in the diagnosis of advanced breast cancer and colon cancer in the U.S. 3Health News:Racial disparities persist in the diagnosis of advanced breast cancer and colon cancer in the U.S. 4Health News:Low forms of cyclin E reduce breast cancer drug's effectiveness 2Health News:Low forms of cyclin E reduce breast cancer drug's effectiveness 3
... Ascension Orthopedics, Inc., a,leader in orthopedic extremity implants, ... Warrender, Jr., John F. Walters and David,C. Furr, ... and,experience will make a substantial contribution to the ... on April 14 as Senior Vice President of,Global ...
... Pharmaceuticals, Inc. (NASDAQ: MIPI) announced today that it ... its Trofex molecular imaging program for the detection ... is designed to investigate two small molecule radiopharmaceutical ... and MIP-1095, in order to select a lead ...
... 2008: Certain single nucleotide polymorphisms (SNPs) within the interleukin ... be associated with juvenile idiopathic arthritis (JIA), according to ... at EULAR 2008, the Annual Congress of the European ... study, three specific SNPs (small variations in the genetic ...
... serving up a surprise not only for tomato lovers around ... bacterium that causes misery for millions of people. , In ... One , researchers say they,ve identified a molecular trick that ... the University of Rochester Medical Center has identified a protein ...
... Injury Is Key, WASHINGTON, June 13 ... will fly to Germany on Saturday,to work with ... in,assessing their current rehabilitation practices. They will also ... care given to,injured soldiers and other military personnel ...
... Dental Management,Services, Inc. (Nasdaq: BDMS ), operators ... dividend. The Company,s board of directors,has declared a ... of common,stock. The dividend is payable July 11, ... Birner Dental Management Services, Inc. acquires, develops, and ...
Other Medicine News:Health News:Three Industry Veterans Join Ascension Orthopedics 2Health News:Three Industry Veterans Join Ascension Orthopedics 3Health News:Molecular insight begins Trofex Phase 1 trial for detection of metastatic prostate cancer 2Health News:Specific mutations in the IL2RA gene associated with juvenile idiopathic arthritis 2Health News:Salmonella: Trickier than we imagined 2Health News:Salmonella: Trickier than we imagined 3Health News:National Rehabilitation Hospital Team to Work with US Army to Improve Rehab Care for Wounded Soldiers 2Health News:National Rehabilitation Hospital Team to Work with US Army to Improve Rehab Care for Wounded Soldiers 3Health News:National Rehabilitation Hospital Team to Work with US Army to Improve Rehab Care for Wounded Soldiers 4Health News:National Rehabilitation Hospital Team to Work with US Army to Improve Rehab Care for Wounded Soldiers 5
... This CLS number ... number, created to easily ... If showing no availability ... the old Sigma-Aldrich number ...
Calibrated"to deliver"with blow-out, andpacked in a flip-top canister to keep the pipets racked. Feature: subdivision 0.1 mL volume 5.0 mL...
Corning 7078 Calibrated"to deliver". multi-pack plugged capacity 5 mL...
These reusable 0.1mL PYREX serological pipets are color coded by size for easy identification and sorting. Colored graduations are enameled onto the glass. These "to deliver" (TD) pipets must be blow...
Medicine Products: